48 thousand doses of Oxford-AstraZeneca received through COVAX FacilitySociety
Ulaanbaatar /MONTSAME/. On June 6, the Government of Mongolia received 48,000 doses of Oxford-AstraZeneca (AZD1222) vaccine through the COVAX Facility.
As part of the vaccines that were allocated to Mongolia for the first half of 2021, AstraZeneca (AZD1222) and Pfizer/BioNTech (BNT162) vaccines were previously received in March, April, and May. With this, the shipment of vaccines that were allocated to Mongolia for the first half of 2021 is complete.
Vaccination works are currently underway to involve priority populations as defined under the National Deployment and Vaccination Plan.